// App-Quantinova.ai

PB/LB02 : Low 1-Year Venous Thromboembolic Recurrence Rates in Patients with and without Thrombotic Risk Factors in Routine Clinical Practice Treated with Edoxaban: The Global ETNA-VTE Study

Researchers

Presenter

  • A. Cohen

Principal Investigators

  • C. Chen

  • K.-M. Chiu

  • W.-I. Choi

  • M. Nakamura

  • W. Zierhut

  • P.-E. Reimitz

  • M. Unverdorben

  • G. Agnelli

Medical Centers

  • Guy's and St Thomas' NHS Foundation Trust and Kings College Medical School, London, United Kingdom

  • Daiichi Sankyo, Inc., Global Medical Affairs, Basking Ridge, United States

  • Far Eastern Memorial Hospital, Cardiovascular Center, New Taipei City, Taiwan, Republic of China

  • Yuan Ze University, Electrical Engineering, Taoyuan, Taiwan, Republic of China

  • Hanyang University Myongji Hospital, Department of Internal Medicine, Goyang-si, Korea, Republic of

  • Nakamura Medical Clinic, Department of Internal Medicine, Pediatrics and Cardiology, Kuwana, Japan

  • Daiichi Sankyo Europe GmbH, Medical Affairs Europe, Munich, Germany

  • Daiichi Sankyo Europe GmbH, Clinical Operations and Biostatistics and Data Operations, Munich, Germany

  • University of Perugia, Internal and Cardiovascular Medicine – Stroke Unit, Perugia, Italy

Locations

  • United Kingdom

  • United States

  • Republic of South Korea

  • Japan

  • Germany

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Edoxaban

Outcome

  • N/A

Study Design

  • Non Interventional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved